methyl 5-(tert-butyl)-1H-pyrrole-2-carboxylate | 27350-41-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: methyl 5-(tert-butyl)-1H-pyrrole-2-carboxylate
• 英文别名: methyl 5-tert-butylpyrrole-2-carboxylate；methyl 5-tert-butyl-1H-pyrrole-2-carboxylate
• CAS: 27350-41-0
• 化学式: C₁₀H₁₅NO₂
• 分子量: 181.235
• InChiKey: NMXYQSHRQHBXSV-UHFFFAOYSA-N

物化性质

• 沸点：
  284.1±28.0 °C(Predicted)
• 密度：
  1.051±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  methyl 5-(tert-butyl)-1H-pyrrole-2-carboxylate 在 palladium on activated charcoal 硫酸 、 氢气 、 硝酸 作用下， 生成 甲基3-氨基-5-(2-甲基-2-丙基)-1H-吡咯-2-羧酸酯
  参考文献：
  名称：

  p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

  摘要：

  Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00574-6
• 作为产物：
  描述：

  2-吡咯甲酸甲酯 在 三甲基铝 作用下， 以 甲醇 为溶剂， 生成 methyl 5-(tert-butyl)-1H-pyrrole-2-carboxylate
  参考文献：
  名称：

  p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

  摘要：

  Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00574-6

文献信息

• UREA INHIBITORS OF MAP KINASES
  申请人：NGUYEN Duyan

  公开号：US20100041642A1

  公开（公告）日：2010-02-18

  Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.

  本文描述了含有抑制MAP激酶的尿素类化合物、包括这些化合物的药物组合物以及使用这些化合物治疗炎症性疾病和癌症的方法。
• Inhibition of p38 kinase activity by aryl ureas
  申请人：Bayer Corporation

  公开号：US06344476B1

  公开（公告）日：2002-02-05

  This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

  本发明涉及一组芳香脲在治疗非癌症的细胞因子介导疾病和非癌症的蛋白水解酶介导疾病中的用途，以及用于此类治疗的药物组合物。
• Inhibition of raf kinase activity using aryl ureas
  申请人：Onyx Pharmaceuticals

  公开号：US06187799B1

  公开（公告）日：2001-02-13

  Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

  利用替代脲化合物治疗由raf激酶介导的肿瘤的方法，以及这些化合物本身。
• Pyrrole and Oligopyrrole Synthesis by 1,3-Dipolar Cycloaddition of Azomethine Ylides with Sulfonyl Dipolarophiles
  作者：Rocío Robles-Machín、Ana López-Pérez、María González-Esguevillas、Javier Adrio、Juan Carlos Carretero

  DOI：10.1002/chem.201000742

  日期：2010.8.23

  A procedure for the synthesis of functionalized, substituted pyrroles by 1,3‐dipolar cycloaddition of azomethine ylides has been developed. This protocol is based on the metal‐catalyzed cycloaddition of α‐iminoesters with sulfonyl dipolarophiles, followed by the base‐promoted elimination of the sulfonyl groups. A wide variety of 2,5‐disubstituted and 2,3,5‐ and 2,4,5‐trisubstituted pyrroles have been

  已开发了通过1,3-偶极环加成甲亚胺基团合成功能化的取代吡咯的方法。该方案基于α-亚氨基酯与磺酰基双极性亲和剂的金属催化环加成反应，然后是碱促进的磺酰基基团消除。由1,2-双（磺酰基乙烯），β-磺烯酮和β-磺酰基丙烯酸酯制备了令人满意的各种2,5-二取代的吡咯和2,3,5-和2,4,5-三取代的吡咯。该方法可以以迭代和直接的方式应用于从双吡咯到五吡咯的低聚吡咯的构建。迭代[ n +1]和[ n+2]的方法已经被设计出来，后者涉及从吡咯基的双（亚氨基酸酯）中双1,3-偶极环加成反应。
• Visible-Light Sensitization of Vinyl Azides by Transition-Metal Photocatalysis
  作者：Elliot P. Farney、Tehshik P. Yoon

  DOI：10.1002/anie.201308820

  日期：2014.1.13

  Irradiation of vinyl and aryl azides with visible light in the presence of Ru photocatalysts results in the formation of reactive nitrenes, which can undergo a variety of CN bond‐forming reactions. The ability to use low‐energy visible light instead of UV in the photochemical activation of azides avoids competitive photodecomposition processes that have long been a significant limitation on the synthetic

  在 Ru 光催化剂存在下用可见光照射乙烯基和芳基叠氮化物会导致反应性氮烯的形成，氮烯可以进行各种 C  N 键形成反应。在叠氮化物的光化学活化中使用低能可见光代替紫外线的能力避免了竞争性光分解过程，而竞争性光分解过程长期以来一直是这些反应合成应用的重大限制。